ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
56,888.47
-6.13%
S&P 500
5,035.69
-1.57%
Dow Jones
37,815.92
-1.49%
US Dollar vs Yen
157.9655
0.15%
Brent Oil
85.095
-0.93%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. REGENXBIO Inc (RGNX)

  7. REGENXBIO Inc (RGNX) ニュース

RGNX REGENXBIO Inc

15.35
0.00 (0.00%)
プレマーケット
最終更新日： 17:09:35
15分遅延
名称 銘柄コード 市場 種別
REGENXBIO Inc RGNX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.00 0.00% 15.35 17:09:35
始値 安値 高値 終値 前日終値
15.35
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2420:05PRNUSREGENXBIO to Participate in Chardan's 8th Annual Genetic..
2024/3/2820:05PRNUSREGENXBIO Announces Lancet Publication of Phase I/IIa Study..
2024/3/2805:05PRNUSREGENXBIO to Participate in Cantor Fitzgerald's Virtual DMD..
2024/3/1121:00EDGAR2Form 8-K - Current report
2024/3/1120:05PRNUSREGENXBIO to Participate in Upcoming Investor Conferences
2024/3/0820:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/3/0808:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0720:03EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
2024/3/0713:20PRNUSREGENXBIO Announces Pricing of Upsized Public Offering of..
2024/3/0706:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/3/0706:10PRNUSREGENXBIO Announces Proposed Public Offering of Common Stock
2024/3/0606:26EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0521:05PRNUSREGENXBIO ANNOUNCES NEW POSITIVE INITIAL EFFICACY DATA FROM..
2024/3/0106:57PRNUSREGENXBIO to Host Webcast Event to Discuss New Interim..
2024/2/2806:54EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2806:10EDGAR2Form 8-K - Current report
2024/2/2806:05PRNUSREGENXBIO Reports Fourth Quarter and Full Year 2023..
2024/2/2121:05PRNUSREGENXBIO to Host Conference Call on February 27 to Discuss..
2024/2/1708:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0801:40PRNUSREGENXBIO Announces Pivotal Trial of RGX-121 for the..
2024/2/0721:05PRNUSREGENXBIO Announces Completion of Enrollment in Cohort 2 and..
2024/1/3121:05PRNUSREGENXBIO Announces Presentations at the 20th Annual..
2024/1/1908:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1706:22EDGAR2Form 144 - Report of proposed sale of securities
2024/1/1704:47PRNUSREGENXBIO Announces Positive Interim Data from Phase II..
2024/1/1021:05PRNUSREGENXBIO Announces Presentation at the Hawaiian Eye and..
2024/1/0821:05PRNUSU.S. District Court Issues Decision on REGENXBIO and..
2024/1/0506:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:21EDGAR2Form 144 - Report of proposed sale of securities
2023/12/2203:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2006:29EDGAR2Form 144 - Report of proposed sale of securities
2023/11/2921:05PRNUSREGENXBIO Announces Dose Escalation in AFFINITY DUCHENNE®..
2023/11/0906:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0906:10EDGAR2Form 8-K - Current report
2023/11/0906:05PRNUSREGENXBIO Announces Updated Strategic Plans and Third..
2023/11/0721:05PRNUSREGENXBIO to Participate in Upcoming Investor Conferences
2023/11/0407:53PRNUSREGENXBIO Presents Positive One Year Data from Phase II..
2023/11/0120:05PRNUSREGENXBIO to Host Conference Call on November 8 to Discuss..
2023/10/3020:05PRNUSREGENXBIO Announces Presentations at the American Academy of..
2023/10/0520:05PRNUSREGENXBIO to Participate in the Jefferies CNS/Neuro Summit
2023/10/0405:05PRNUSREGENXBIO Presents Interim Clinical Data from Phase I/II..
2023/9/2620:05PRNUSREGENXBIO Announces Presentations at the 28th Annual..
2023/9/0520:05PRNUSREGENXBIO to Participate in Upcoming Investor Conferences
2023/9/0205:42EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/9/0205:12EDGAR2Form 8-K - Current report
2023/8/3020:05PRNUSInitial Clinical Data of First Pediatric CLN2 Patient Dosed..
2023/8/2405:05PRNUSREGENXBIO Announces Presentations at the Society for the..

最近閲覧した銘柄

NASDAQ
RGNX
REGENXBIO
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有